Non-WMO research with a medicinal product, research with a medicinal product not subject to CTR

Research with a medicinal product that does not fall within the scope of CTR and that is initiated and/or financed by pharmaceutical companies (where the content and/or execution of the research can be influenced by the company) must be reviewed in advance according to the DCRF review framework for non-WMO research with a medicinal product. Information about the review framework and the review procedure can be found on the website  nWMO-studies (in Dutch) of the Dutch Clinical Research Foundation (DCRF). Non-interventional safety studies at the request of a European registration authority are exempt from the DCRF review framework.